๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
400 medicines starting with โ€œIโ€
MedicineActive substanceLicence holderStatus
IDACIO 40 mg Solution for injection
EU/1/19/1356/002
Adalimumab Fresenius Kabi Deutschland GmbH โ€”
IDACIO 40 mg Solution for injection
EU/1/19/1356/003
Adalimumab Fresenius Kabi Deutschland GmbH โ€”
IDACIO 40 mg/0.8 ml Solution for injection
EU/1/19/1356/001
Adalimumab Fresenius Kabi Deutschland GmbH โ€”
Idefirix 11 mg powder for concentrate for solution for infusion
EU/1/20/1471/001-002
Imlifidase Hansa Biopharma AB โ€”
IDELVION 1000 IU powder and solvent for solution for injection
EU/1/16/1095/003
Rix-fp CSL Behring GmbH โ€”
IDELVION 2000 IU powder and solvent for solution for injection
EU/1/16/1095/004
Rix-fp CSL Behring GmbH โ€”
IDELVION 250 IU powder and solvent for solution for injection
EU/1/16/1095/001
Rix-fp CSL Behring GmbH โ€”
IDELVION 3500 IU powder and solvent for solution for injection
EU/1/16/1095/009
Albutrepenonacog Alfa CSL Behring GmbH โ€”
IDELVION 500 IU powder and solvent for solution for injection
EU/1/16/1095/002
Rix-fp CSL Behring GmbH โ€”
IDEOS 500mg/400 IU Chewable Tablets
PA1033/001/001
Calcium, Colecalciferol Laboratoire Innotech International Marketed
Idrolax 10g, powder for oral solution in a sachet
PA22808/001/001
Macrogol 4000 Mayoly Pharma France Not marketed
IELMAG3 0.2 mg kit for radiopharmaceutical preparation
PA2226/001/001
Mertiatide ROTOP Pharmaka GmbH Marketed
Ifirmacombi 150 mg/12.5 mg film-coated tablets
EU/1/11/673/001-008
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto โ€”
Ifirmacombi 300 mg/12.5 mg film-coated tablets
EU/1/11/673/009-016
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto โ€”
Ifirmacombi 300 mg/25 mg film-coated tablets
EU/1/11/673/017-024
Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto โ€”
Ifirmasta 150 mg film-coated tablets
EU/1/08/480/7-12
Irbesartan KRKA, d.d., Novo mesto โ€”
Ifirmasta 300 mg film-coated tablets
EU/1/08/480/13-18
Irbesartan KRKA, d.d., Novo mesto โ€”
Ifirmasta 75 mg film-coated tablets
EU/1/08/480/1-6
Irbesartan KRKA, d.d., Novo mesto โ€”
IKERVIS 1 mg/mL eye drops, emulsion
EU/1/15/990/001-002
Ciclosporin Santen OY โ€”
Ilaris 150 mg powder for solution for injection
EU/1/09/564/1-2
Canakinumab Novartis Europharm Limited โ€”
Ilaris 150 mg/ml solution for injection
EU/1/09/564/004
Canakinumab Novartis Europharm Limited โ€”
Illuccix 25 micrograms kit for radiopharmaceutical preparation
PA23504/001/001
Gozetotide Telix Innovations Not marketed
Ilumetri
EU/1/18/1323/001
Tildrakizumab Almirall, S.A. โ€”
Ilumetri 200 mg solution for injection in pre-filled syringe
EU/1/18/1323/003
Tildrakizumab Almirall S.A. โ€”
ILUVIEN 190 micrograms intravitreal implant in applicator
PA22620/001/001
Fluocinolone acetonide Alimera Sciences Europe Limited, Marketed
Ilvico Cold and Flu film-coated tablets Paracetamol 325 mg Caffeine 30 mg Brompheniramine maleate 3 mg
PA22703/001/001
Paracetamol, BROMPHENIRAMINE MALEATE, Caffeine P&G Health Germany GmbH Marketed
Imatinib Accord 100 mg film-coated tablets
EU/1/13/845/001-008
Imatinib mesilate Accord Healthcare S.L.U. โ€”
Imatinib Accord 400 mg film-coated tablets
EU/1/13/845/009-014
Imatinib mesilate Accord Healthcare S.L.U. โ€”
Imatinib Krka d.d 100 mg film-coated tablets
PA1347/054/001
Imatinib KRKA, d.d., Novo mesto Marketed
Imatinib Krka d.d. 400 mg film-coated tablets
PA1347/054/002
Imatinib KRKA, d.d., Novo mesto Marketed
Imatinib Rowex 100 mg film-coated tablets
PA0711/248/001
Imatinib Rowex Limited, Marketed
Imatinib Rowex 400 mg film-coated tablets
PA0711/248/002
Imatinib Rowex Limited, Marketed
Imatinib Teva 100 mg film-coated tablets
EU/1/12/808/001-012
Imatinib mesilate Teva B.V. โ€”
Imatinib Teva 100 mg hard capsules
EU/1/12/808/021-032
Imatinib mesilate Teva Pharma B.V. โ€”
Imatinib Teva 400 mg film-coated tablets
EU/1/12/808/013-020
Imatinib mesilate Teva Pharma B.V. โ€”
Imatinib Teva 400 mg hard capsules
EU/1/12/808/033-040
Imatinib mesilate Teva Pharma B.V. โ€”
IMBRUVICA 140 mg film-coated tablets
EU/1/14/945/007-008
Ibrutinib Janssen-Cilag International NV โ€”
IMBRUVICA 140 mg hard capsules
EU/1/14/945/001-002
Ibrutinib Janssen-Cilag International NV โ€”
IMBRUVICA 280 mg film-coated tablets
EU/1/14/945/009-010
Ibrutinib Janssen-Cilag International NV โ€”
IMBRUVICA 420 mg film-coated tablets
EU/1/14/945/005
Ibrutinib Janssen-Cilag International NV โ€”
IMBRUVICA 560 mg film-coated tablets
EU/1/14/945/006
Ibrutinib Janssen-Cilag International NV โ€”
IMCIVREE 10 mg/ml solution for injection
EU/1/21/1564/001
Setmelanotide Rhythm Pharmaceuticals Netherlands B.V โ€”
Imdur 60 mg Prolonged-release Film-coated Tablets
PA2129/001/001
ISOSORBIDE MONONITRATE Topridge Pharma (Ireland) Limited Marketed
IMFINZI 50 mg/ml concentrate for solution for infusion.
EU/1/18/1322/001-002
Durvalumab AstraZeneca AB โ€”
Imigran 10 mg Nasal Spray, Solution
PA1077/008/003
Sumatriptan GlaxoSmithKline (Ireland) Limited Marketed
Imigran 20 mg nasal spray, solution
PA1077/008/004
Sumatriptan GlaxoSmithKline (Ireland) Limited Marketed
Imigran 20 mg nasal spray, solution
PPA1463/211/001
Sumatriptan IMED Healthcare Ltd. โ€”
Imigran Ftab 100 mg film-coated tablets
PA1077/008/007
Sumatriptan GlaxoSmithKline (Ireland) Limited Marketed
Imigran Ftab 50 mg film-coated tablets
PA1077/008/006
Sumatriptan GlaxoSmithKline (Ireland) Limited Marketed
Imigran Ftab 50 mg film-coated tablets
PPA1463/211/002
Sumatriptan IMED Healthcare Ltd., โ€”
โ† 1 2 3 4 5 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.